🇺🇸 FDA
Patent

US 8759327

Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

granted A61PA61P3/10A61P35/00

Quick answer

US patent 8759327 (Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P3/10, A61P35/00, A61P9/10